Mapping Sentinel Lymph Node in Initial Stages of Ovarian Cancer
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Tempus Priority Study: A Pan-tumor Observational Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study on the Consistency Evaluation of Organoids Used in the Clinical Treatment of Ovarian Cancer With Anti-tumor Drugs
- Status
- UNKNOWN
- Phase
- N/A
CADx - Radiomics to Distinguish the Origin of Ovarian Tumors
- Status
- UNKNOWN
- Phase
- N/A
A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Michigan Genetic Hereditary Testing (MiGHT)
- Status
- COMPLETED
- Phase
- NA
Tamoxifen and SUBA-Itraconzole Combination Testing in Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Avera Cancer Sequencing and Analytics Protocol (ASAP)
- Status
- RECRUITING
- Phase
- N/A
Assessments of Genetic Counseling Augmented With an Educational Video or Pamphlet Versus Traditional Counseling
- Status
- COMPLETED
- Phase
- NA
Registry Platform Ovarian and Endometrial Cancer
- Status
- RECRUITING
- Phase
- N/A
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
- Status
- RECRUITING
- Phase
- PHASE2
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
- Status
- RECRUITING
- Phase
- PHASE2
First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine
- Status
- RECRUITING
- Phase
- PHASE1
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Asian Multicenter Prospective Study of ctDNA Sequencing
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A